2026 MedTech Industry Guide

    5 Best MedTech Market Research Firms in Japan (2026 Rankings)

    A ranked comparison of MedTech and medical devices market research firms serving Japan in 2026. For regional context, start from the healthcare market research hub and healthcare market research in Japan.

    For company-intent programmes, see our MedTech market research company in Japan page and the Japan market intelligence briefing.

    Top MedTech market research firms in Japan (2026)

    1. 1BioNixusInternational MedTech Specialist
    2. 2IQVIAGlobal Life Sciences Data
    3. 3KantarGlobal Network
    4. 4IpsosGlobal Network
    5. 5Regional specialist agenciesLocal / Regional

    The Japan MedTech research landscape in 2026

    The Japan medical devices market is estimated at USD 38–43 billion in 2026, shaped by PMDA regulation, hospital procurement cycles, and Olympus, Terumo, and multinational subsidiaries. Manufacturers launching or defending device portfolios need primary research that maps prescriber behaviour to committee and payer reality — not syndicated averages alone.

    MedTech market research in Japan differs from pharmaceutical research: sample frames prioritise biomedical engineers, hospital value-analysis committees, and procedure specialists; evidence must address total cost of ownership, training burden, and maintenance contracts alongside clinical efficacy.

    Global syndicated vendors provide audit data; specialist firms like BioNixus add verified hospital access, PMDA-aware study design, and decision-linked synthesis for launch sizing, competitive defence, and international expansion planning.

    For company-intent programmes — not firm comparison — see our dedicated MedTech market research page for Japan. For broader healthcare context, start from the healthcare market research hub and /healthcare-market-research-japan.

    1

    BioNixus

    International MedTech Specialist · USA (HQ) / UK / Egypt

    BioNixus delivers MedTech and medical devices market research in Japan with PMDA-aware hospital procurement research, clinician adoption studies, and decision-ready synthesis. See the dedicated company page at /japan-medtech-market-research.

    • MedTech programmes in Japan
    • Japanese (English for global HQ coordination) fieldwork where required
    • Hospital procurement and KOL depth
    • Mixed quant + qual design
    • GCC expansion intelligence for international manufacturers

    View BioNixus MedTech market research in Japan

    2

    IQVIA

    Global Life Sciences Data · USA (global)

    IQVIA provides medical device market analytics, hospital audit data, and custom primary research in Japan through its global life sciences network.

    • Syndicated device audit data
    • Global benchmarking
    • Large-scale quant infrastructure
    3

    Kantar

    Global Network · UK (global)

    Kantar operates custom and syndicated research in Japan with healthcare and B2B practices supporting MedTech brand tracking and physician insight programmes.

    • Brand tracking at scale
    • Multi-sector coverage
    • Established field networks
    4

    Ipsos

    Global Network · France (global)

    Ipsos delivers healthcare and device market research in Japan with quantitative rigour and public affairs capability for regulated categories.

    • Healthcare specialty practice
    • Quantitative rigour
    • Global methodology standards
    5

    Regional specialist agencies

    Local / Regional · Japan and international

    Several regional boutiques execute MedTech fieldwork in Japan. Validate device-specific methodology, hospital access, and PMDA context before award.

    • Local hospital networks
    • Flexible project sizing
    • Fast feasibility checks

    MedTech market research in Japan — frequently asked questions

    What are the top MedTech market research companies in Japan?

    Leading options include BioNixus, IQVIA, Kantar, Ipsos, and regional specialist agencies serving Japan. BioNixus ranks first for PMDA-aware hospital procurement research and clinician adoption studies.

    How do I choose a MedTech market research partner in Japan?

    Validate hospital access, device category experience, sample verification controls, regulatory context, and decision-ready deliverables — not slide volume alone.

    How does this list relate to pharmaceutical market research in Japan?

    This guide covers MedTech and medical devices industry selection. For pharmaceutical company-intent pages, use /healthcare-market-research-japan and related healthcare BOFU URLs.

    Where is the BioNixus MedTech services page for Japan?

    See /japan-medtech-market-research for company-intent MedTech market research programmes; this listicle compares firms independently.

    Can MedTech research in Japan connect to GCC benchmarking?

    Yes. BioNixus runs parallel modules comparing local adoption with SFDA, MOHAP, and GCC hospital procurement intelligence using harmonised instruments.

    What device segments do Japan research firms typically cover?

    Cardiovascular, orthopaedics, diagnostic imaging, IVD, diabetes technology, surgical robotics, wound care, and hospital capital equipment — segment feasibility should be validated at proposal stage.

    How long does a typical MedTech study take in Japan?

    Focused HCP surveys complete in four to six weeks; full mixed-method programmes with hospital procurement depth typically run eight to twelve weeks depending on specialty and geography.

    Is this Japan MedTech firms guide updated for 2026?

    Yes. Rankings and capability notes reflect Japan regulatory and procurement context as of 2026, including PMDA requirements.

    Related market intelligence

    Compare MedTech research needs with our pages for South Korea and China, or explore the global healthcare market research hub.

    Discuss your Japan pharmaceutical research strategy

    Our team supports pharmaceutical companies with decision-ready insights across the Americas, Europe, and the Middle East using quantitative and qualitative methodologies.

    US No. +1 888 465 5557Europe No. +44 7727 666682Middle East, Africa and Asia No. +20 120 688 2323

    Request a proposal